Frequency of Chronic Headaches in Japanese Patients With Multiple Sclerosis: With Special Reference to Opticospinal and Common Forms of Multiple Sclerosis

Background.— Headache is common in Western patients with multiple sclerosis (MS), but its frequency has not been reported in Asian patients. In Asians, the opticospinal form of MS, showing similar characteristics to relapsing neuromyelitis optica in Westerners, is regarded as a different subtype from conventional MS.

[1]  S. Pittock,et al.  Neuromyelitis Optica , 2019, Definitions.

[2]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[3]  G. Carpino,et al.  An overview on immune system and migraine. , 2007, European review for medical and pharmacological sciences.

[4]  Y. Fragoso,et al.  Two Cases of Lesions in Brainstem in Multiple Sclerosis and Refractory Migraine , 2007, Headache.

[5]  A. Rigamonti,et al.  Interferon treatment may trigger primary headaches in multiple sclerosis patients , 2006, Multiple sclerosis.

[6]  J. Kira,et al.  Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis , 2006, Journal of the Neurological Sciences.

[7]  Massimo Filippi,et al.  Brain Gray Matter Changes in Migraine Patients With T2-Visible Lesions: A 3-T MRI Study , 2006, Stroke.

[8]  B. Weinshenker,et al.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. , 2006, Archives of neurology.

[9]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[10]  M. Filippi,et al.  Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis , 2006, Journal of the Neurological Sciences.

[11]  B. Weinshenker,et al.  Brain abnormalities in neuromyelitis optica. , 2006, Archives of neurology.

[12]  I. Fidan,et al.  The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine , 2006, Journal of Neuroimmunology.

[13]  A. Dublin,et al.  The Association of Brainstem Lesions With Migraine‐Like Headache: An Imaging Study of Multiple Sclerosis , 2005, Headache.

[14]  F. Mihara,et al.  Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. , 2005, Brain : a journal of neurology.

[15]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[16]  C. Besta,et al.  Prevalence of Primary Headaches in People with Multiple Sclerosis , 2004, Cephalalgia : an international journal of headache.

[17]  J. Kira,et al.  Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b , 2004, Journal of the Neurological Sciences.

[18]  K. Nakashima,et al.  Population‐Based Door‐to‐Door Survey of Migraine in Japan: The Daisen Study , 2004, Headache.

[19]  J. Kira.  Multiple sclerosis in the Japanese population , 2003, The Lancet Neurology.

[20]  A. Straube,et al.  Interferon beta but not glatiramer acetate therapy aggravates headaches in MS , 2002, Neurology.

[21]  V. Nagesh,et al.  Functional MRI-BOLD of brainstem structures during visually triggered migraine , 2002, Neurology.

[22]  Hans Lassmann,et al.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.

[23]  P. Goadsby,et al.  The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? 1 1 Presented in part at the Xth International Headache Congress, Barcelona, Spain, 24–26 June 1999 [Knight and Goadsby, Cephalalgia 19 (1999) 315]. , 2001, Neuroscience.

[24]  M. Marinaro,et al.  Immunological Aspects in Migraine: Increase of IL‐10 Plasma Levels During Attack , 2001, Headache.

[25]  N Gelman,et al.  Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness? , 2001, Headache.

[26]  F. Mihara,et al.  HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. , 1999, Brain : a journal of neurology.

[27]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[28]  J. Cano,et al.  Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs , 1999, Neuroscience.

[29]  M. Marinaro,et al.  Cytokines and Migraine: Increase of IL‐5 and IL‐4 Plasma Levels , 1998, Headache.

[30]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[31]  Shozo Tobimatsu,et al.  Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders , 1996, Annals of neurology.

[32]  D. Friedman,et al.  Headache Caused by a Single Lesion of Multiple Sclerosis in the Periaqueductal Gray Area , 1993, Headache.

[33]  K. Tashiro,et al.  Acute transverse myelopathy in multiple sclerosis , 1990, Journal of the Neurological Sciences.

[34]  L. Rolak,et al.  Headaches and multiple sclerosis: a clinical study and review of the literature , 1990, Journal of Neurology.

[35]  M. Freedman,et al.  Vascular Headache: A Presenting Symptom of Multiple Sclerosis , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[36]  A. A. Eisen,et al.  MRI in the diagnosis of MS , 1988, Neurology.

[37]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[38]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[39]  松岡 健.  Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese , 2009 .

[40]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .